Position in JNJ
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$939,435
+$78,029 QoQ
Shares Held
3,699
+5.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.79%
of 13F equity value
Holder Rank
#3,074
of 4,676 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 73%
Shared 0%
None 27%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Family Capital Management, Inc. holds $6,119,827 across 8 Drug Manufacturers - General names. JNJ ranks #3 (15.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
9,999 | $1,284,871 | |
| 2 | LLY |
ELI LILLY & Co
|
865 | $1,037,507 | |
| 3 | JNJ |
Johnson & Johnson
This page
|
3,699 | $939,435 | |
| 4 | ABBV |
AbbVie Inc.
|
3,529 | $888,037 | |
| 5 | PFE |
Pfizer Inc
|
28,226 | $679,682 | |
| 6 | AZN |
Astrazeneca PLC
|
2,926 | $554,828 | |
| 7 | NVS |
Novartis AG
|
3,309 | $518,586 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
3,764 | $216,881 |
All Filings in JNJ
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $939,435 | 3,699 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $861,406 | 3,524 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $686,453 | 3,317 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $560,895 | 3,025 | Shares | Sole | 2025-10-27 | |
| 2025-06-30 | $437,170 | 2,862 | Shares | Sole | 2025-07-30 | |
| No filing history on record for this holder in this stock. | ||||||